Peter S Kim's Net Worth

$29.6 Million

Estimate Recalculated Jun 18, 2025 08:33PM EST

Who is Peter S Kim

Peter S Kim has an estimated net worth of $29.6 Million. This is based on reported shares across multiple companies, which include Merck & Co. Inc., Entrada Therapeutics, Inc., and MERCK & CO INC.

SEC CIK

Peter S Kim's CIK is 0001181180

Past Insider Trading and Trends

2009 was Peter S Kim's most active year for acquiring shares with 19 total transactions. Peter S Kim's most active month to acquire stocks was the month of February. 2009 was Peter S Kim's most active year for disposing of shares, totalling 18 transactions. Peter S Kim's most active month to dispose stocks was the month of October. 2012 saw Peter S Kim paying a total of $12,446,424.38 for 671,350 shares, this is the most they've acquired in one year. In 2012 Peter S Kim cashed out on 850,000 shares for a total of $19,110,672.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Merck & Co. Inc.

Exe V-P & Pres, MRL
Updated Feb 27, 2013
Form 4
11.07%
18.90K
$42.52
$803.76K
Feb 27, 2013
190.96K
Grant
Feb 25
Form 4
-71.10%
-420.00K
$36.81
-$7.31M
Nov 06, 2012
172.04K
Sale
Nov 05
Form 4
124.32%
224.65K
May 04, 2012
406.67K
Grant
May 02
Form 4
10.18%
16.70K
$38.38
$640.98K
Mar 01, 2012
182.00K
Grant
Feb 28
Form 4
240.29K
May 06, 2011
405.55K
Grant
May 04
Form 4
-4.94%
-8.53K
$32.19
-$969.88K
Mar 01, 2011
165.24K
Options
Feb 28
Form 4
13.57%
18.04K
$32.34
$583.32K
Feb 24, 2011
152.17K
Grant
Feb 22
Form 4
209.93K
May 11, 2010
344.02K
Grant
May 07
Form 4
-10.25%
-15.18K
$37.27
-$1.97M
Mar 04, 2010
134.08K
Options
Mar 02
Form 4
19.25%
17.83K
$37.72
$672.66K
Jan 26, 2010
111.65K
Grant
Jan 08
Form 4
1.42M
Nov 05, 2009
Acq/Dis
Nov 03
Form 3
Nov 05, 2009
Showing 12 results

Entrada Therapeutics, Inc.

Investor
Updated Jun 18, 2025
Form 4/A
74.17%
50.00K
$14.63
$731.68K
Jun 18, 2025
117.41K
Purchase
May 13 - May 14
Form 4
16.00K
Jun 14, 2024
16.00K
Grant
Jun 13
Form 4
$6.06
$72.22K
Jun 05, 2024
104.33K
Options
Jun 03
Form 4
37.09%
25.00K
$14.59
$364.67K
May 16, 2024
92.41K
Purchase
May 14
Form 4
7.11%
4.48K
$14.14
$63.31K
May 10, 2024
67.41K
Purchase
May 08 - May 09
Form 4
4.31%
2.60K
$13.57
$35.29K
Apr 10, 2024
62.94K
Purchase
Apr 08
Form 4
2.57%
1.51K
$13.75
$20.79K
Apr 01, 2024
60.34K
Purchase
Mar 28
Form 4
18.18%
9.05K
$13.58
$122.88K
Mar 26, 2024
58.82K
Purchase
Mar 22 - Mar 26
Form 4
5.81%
2.73K
$12.81
$35.00K
Mar 21, 2024
49.78K
Purchase
Mar 19 - Mar 21
Form 4
16.00K
Jun 12, 2023
16.00K
Grant
Jun 08
Form 4
11.92K
Jun 06, 2022
11.92K
Grant
Jun 02
Form 4
11.92K
Nov 01, 2021
11.92K
Grant
Oct 28
Form 3
Oct 28, 2021
47.04K
Showing 13 results

MERCK SHARP & DOHME CORP.

Exec. V-P and Pres., MRL
Updated Nov 04, 2009
Form 4
-100.00%
-1.42M
Nov 04, 2009
Disposition
Nov 03
Form 4
224.00K
Apr 27, 2009
317.56K
Grant
Apr 24
Form 4/A
10.24%
8.56K
$23.05
$197.42K
Apr 27, 2009
92.22K
Grant
Mar 04
Form 4/A
-13.26%
-12.79K
$23.44
-$299.75K
Apr 27, 2009
83.65K
Tax
Mar 03
Form 4
9.49%
7.77K
$23.05
$179.10K
Mar 06, 2009
90.97K
Grant
Mar 04
Form 4
-11.02%
-14.58K
$23.44
-$1.10M
Mar 05, 2009
119.14K
Options
Mar 03
Form 4
136.80K
Mar 04, 2008
201.92K
Grant
Feb 29
Form 4
22.86%
11.90K
$45.44
$540.55K
Mar 03, 2008
65.12K
Grant
Feb 28
Form 4
-32.42%
-24.97K
$46.07
-$4.22M
Feb 27, 2008
53.23K
Options
Feb 25
Form 4
152.80K
Mar 06, 2007
164.14K
Grant
Mar 02
Form 4
$44.48
Mar 01, 2007
28.01K
Options
Feb 27
Form 4
-31.42%
-4.71K
$44.79
-$211.10K
Jan 17, 2007
11.34K
Tax
Jan 15
Form 4
146.50K
Mar 07, 2006
162.39K
Grant
Mar 03
Form 4
166.67K
Mar 01, 2005
182.38K
Grant
Feb 25
Form 4
116.67K
Mar 02, 2004
132.27K
Grant
Feb 27
Form 4
3,521.13%
15.00K
Jan 20, 2004
15.61K
Grant
Jan 15
Showing 16 results